RELX's Quality and Safety Lab in Shenzhen Accredited by CNAS

Aug.03.2022
RELX's Quality and Safety Lab in Shenzhen Accredited by CNAS
RELX's Shenzhen quality safety lab gains CNAS certification, ensuring global recognition of its testing reports.

On August 2nd, a Blue Whale Finance journalist learned from RELX Yueke (Fogcore Technology) that its quality and safety laboratory in Shenzhen has received recognition from CNAS (China National Accreditation Board for Laboratories).


According to the information provided, CNAS (China National Accreditation Service For Conformity Assessment) is the English abbreviation for the China National Accreditation Committee for Conformity Assessment. Laboratories accredited by CNAS can issue testing reports that are recognized by more than 100 countries worldwide.


As per reports, the Yooz Quality and Safety Laboratory, mentioned earlier, was established in 2021 and covers an area of 450 square meters, serving as a key support component of the Yooz quality system. The laboratory focuses on testing the physical and electrical properties of products and is the second laboratory accredited by CNAS (China National Accreditation Service) within the company, Fogcore Technology. Yooz's first accredited laboratory, dedicated to testing e-liquid, was certified in August 2020, making it the first e-cigarette brand company to receive CNAS accreditation.


In fact, in daily use, electronic cigarettes in the hands of consumers are inevitably subjected to shocks and impacts, as well as challenges from wind, heat, and cold, with their durability and safety directly affecting the user experience. Therefore, in order to pursue top-quality products, YOOZ, in terms of quality and safety testing, has set up multiple tests including friction, drop, and high temperature in its quality safety laboratory. "At present, we have the ability to carry out testing in accordance with national standards," said Yang Yong, head of the YOOZ Quality Compliance Center. "In addition, we have also improved our testing standards by starting from many invisible details.


For example, YUEKE has an exclusively patented system for assessing suction noise, which helps quality engineers monitor the decibel levels of the sounds emitted during product use in real-time to reduce noise levels to the greatest extent possible and achieve "no disturbance" in terms of hearing. Meanwhile, the company also offers optional testing for cosmetics endurance. Engineers apply skincare products to atomizer rods and observe whether the product's appearance changes in high-temperature, high-humidity environments. This process can test the anti-corrosion abilities of different atomizer rods and identify the most durable products for users.


To address the widely-concerned issue of oil leakage, engineers conducted laboratory experiments simulating high-altitude pressures exceeding 3000 meters above sea level, testing atomized bombs. The tested products greatly mitigate oil leakage caused by changes in pressure.


In March of this year, national standards for electronic cigarettes as well as regulations for their management were issued, marking a move towards the legalization and standardization of the electronic cigarette industry. Yang Yong stated that Yooz will take on its quality responsibilities and strive for the highest quality, creating products that have a pure flavor.


It has been reported that YUEKE, since its inception, has invested a total of 800 million yuan in research and development, creating a matrix of eight large laboratories. In addition to the quality and safety laboratory, there are also innovation laboratories, chemical laboratories, life science laboratories, aerosol laboratories, atomization innovation laboratories, new material laboratories, sensory analysis laboratories, and after-sales testing centers. The quality system covers the entire user experience process.


According to Yang Yong, chemical laboratories can analyze the chemical components of aerosols and sprays, while life science laboratories are responsible for safety testing at the cellular and animal levels. By conducting multiple layers of testing, we ensure that the quality and safety of our products are implemented in every detail.


According to reports, the Yueke Chemical Laboratory tests 19 categories of 140 substances and 12 categories of 102 substances for aerosols. The Life Science Laboratory is capable of conducting six tests, such as cell toxicity, to further confirm product safety.


According to reports, Fogtech has recently been awarded the "License for Tobacco Monopoly Production Enterprise (Electronic Cigarette Product Production Enterprise)". Currently, the company is intensively developing new products that meet national standards, and some products have passed technical evaluations. In its statement, Fogtech said it will continue to aim for a perfect user experience and provide high-quality and reassuring products.


This article contains excerpts or reprints from third-party sources, whose copyright belongs to the original media and author. If there is any infringement, please contact us to delete it. Any organization or individual wishing to reprint must contact the author and refrain from reprinting directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10